The Elliot Lewis Center for Multiple Sclerosis Care

Wellesley, Massachusetts

Dedicated MS Practice
5 Active TrialsInfusion CenterLarge Center
15 MS centers statewide · Ranked #5 in Massachusetts for clinical trials · #8 in Massachusetts for provider count
What kind of place is this?
Research FocusedInfusion On-SiteOne Doctor Relationship

You are in a dedicated MS center built around ongoing specialty care, infusion treatment, and research involvement. You can expect a large team, coordinated support, and access to both treatment and study options. This isn't a virtual-first practice, so most care is centered on in-person visits.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access5/5
Support Services4/5
Clinical Trials & Research4/5
Insurance & Navigation Help5/5
Scheduling & Virtual Care3/5

About The Elliot Lewis Center for Multiple Sclerosis Care

This center combines on-site infusion therapy with a clinical research program, giving you access to treatment and study opportunities in one place. It is also a large, dedicated MS practice with a multidisciplinary team.

The Elliot Lewis Center for Multiple Sclerosis Care treats multiple sclerosis, relapsing MS, progressive MS, neuromyelitis optica, MOG associated disease, and transverse myelitis. You can receive neurology consultations, infusion therapies, lab testing at the time of infusion, and support with insurance and financial assistance. The center has a clinical research program and offers a team-based model with physicians, nurses, research staff, and social work support.

The Elliot Lewis Center for Multiple Sclerosis Care is a dedicated MS practice in Wellesley, MA. You can receive care from a multidisciplinary team that includes physicians, nurses, research coordinators, a social worker, and support staff. The center offers both on-site infusion therapy and clinical research. Patients also benefit from insurance and benefits coordination and help with financial assistance program enrollment.

Featured Care Team Members

Joshua Katz, MD
Director
multiple sclerosis, neuromyelitis optica, MOG associated disease, transverse myelitis
Andrew Bouley, MD
Co-Director
multiple sclerosis
Andrew Bouley, M.D.
Active MS Prescriber
Kenneth Gorson, MD
Joshua Katz, MD
Active MS Prescriber

Specialized Programs

on-site infusion center
clinical research program

Services & Treatments

What They Treat
multiple sclerosisrelapsing multiple sclerosisprogressive multiple sclerosisneuromyelitis opticaMOG associated diseasetransverse myelitis
How They Treat It
multiple sclerosis careneurology consultationson-site infusion therapyclinical researchinsurance and benefits coordinationfinancial assistance program enrollmentlab testing at time of infusioninfusion therapiesdisease-modifying therapies
Diagnostics
blood testsfunctional testingMRI discs/images reviewlaboratory testing

Research & Clinical Trials

This center is currently involved in 5 clinical trials — ranked #5 in Massachusetts for active trials

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen

Insurance & Access

Contact
110 Cedar Street Suite 110, Wellesley, MA 02481
Insurance & Support
MedicareMassachusetts Medicaid (MassHealth)most commercial plans
Financial Counseling
Care Coordinator

FAQs from The Elliot Lewis Center for Multiple Sclerosis Care

The center treats multiple sclerosis, relapsing MS, progressive MS, neuromyelitis optica, MOG associated disease, and transverse myelitis. Care is led by specialists who focus on these conditions.

Yes. The Elliot Lewis Center has an on-site infusion center, and infusion treatments are available by appointment Monday through Friday.

Joshua Katz, MD, is the Director, and Andrew Bouley, MD, is the Co-Director. You are also supported by a multidisciplinary team that includes physicians, nurses, research staff, a social worker, and support staff.

Yes. The Elliot Lewis Center has a clinical research program, and it is also listed as having active clinical trials. If you are interested in research participation, the team can help guide you.

The center accepts Medicare, Massachusetts Medicaid (MassHealth), and most commercial plans. It also provides insurance and benefits coordination, financial assistance program enrollment, and a full insurance support process.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website